Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV001817873 | SCV002067283 | pathogenic | not provided | 2019-03-22 | criteria provided, single submitter | clinical testing | DNA sequence analysis of the PARN gene demonstrated a single base pair duplication in exon 12, c.811dup. This pathogenic sequence change results in an amino acid frameshift and creates a premature stop codon 1 amino acid downstream of the mutation, p.Ser271Phefs*2. This pathogenic sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated PARN protein with potentially abnormal function. |
Labcorp Genetics |
RCV003772340 | SCV004568477 | pathogenic | Congenital amegakaryocytic thrombocytopenia; Essential thrombocythemia | 2024-02-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Phe105Argfs*6) in the MPL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MPL are known to be pathogenic (PMID: 8073287, 11133753). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MPL-related conditions. ClinVar contains an entry for this variant (Variation ID: 1338502). For these reasons, this variant has been classified as Pathogenic. |